15, e38398
Phase 3 trials are currently underway, with FDA approval projected between late 2026 and early 2027
If youre struggling with low energy, slow recovery, brain fog, poor sleep, or signs of hormonal decline, peptide therapy may be worth exploring
What GLP-1 Microdosing Really Means GLP-1based medications, including semaglutide and tirzepatide, are prescribed under specific brand names and indications for conditions such as type 2 diabetes and chronic weight management
However, it is still possible that even these drugs might impact MS by changing the circulating metabolic profile of the blood and impacting the peripheral immune system and by interacting with the circumventricular organs in the brain, Shirani said
How Saxenda Works Mimics the GLP-1 hormone to signal fullness to the brain, reducing overall calorie intake